| RS2489102759 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489102854 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489103092 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489103106 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489104166 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489104177 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489104302 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489104342 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489104369 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489106447 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489106564 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489110933 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489110934 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489110954 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489110995 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489111102 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489111109 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489124576 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489124595 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489124599 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489124701 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS2489124753 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489160558 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489160608 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489160614 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489160744 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489161312 |
PLAA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with progressive microcephaly, spasticity |
| RS2489162390 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489162680 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489162816 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489162833 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2489222997 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2489223096 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2489226644 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2489226781 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2489226859 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2489231450 |
CSPP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS2489231786 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489231841 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489231853 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489231873 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489231890 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489231901 |
GRHPR
|
Health Risk |
Likely pathogenic |
— |
| RS2489231928 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489232215 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489232420 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489232465 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489234483 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489234534 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489234631 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489235913 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489235986 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489236019 |
GRHPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type II |
| RS2489236032 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489239934 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489239970 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489240009 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489240019 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489240316 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489242940 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489242953 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489243051 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489243310 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489244935 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489245051 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489245319 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489245598 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489245627 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489248956 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489249100 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489249156 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489249189 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489249374 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489249571 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489258602 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489258701 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2489258743 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2489258749 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2489273553 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489273847 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2489274630 |
RFX3
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2489274805 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489275051 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489275147 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489275366 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489275539 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489275992 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489276462 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489276684 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Melanoma and neural system tumor syndrome, Melanoma and neural system tumor syndrome |
| RS2489276701 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2489277337 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2489278121 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS2489290573 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS2489290714 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489290856 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Melanoma-pancreatic cancer syndrome |
| RS2489290903 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2489291220 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma, cutaneous malignant |
| RS2489291303 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489291666 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2489292008 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |